Reuters logo
BRIEF-RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc
2016年10月12日 / 上午11点17分 / 1 年前

BRIEF-RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc

Oct 12 (Reuters) - RXi Pharmaceuticals Corp :

* RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc

* RXi Pharmaceuticals Corp - can exercise option to acquire Mirimmune on terms set forth in option agreement at any time prior to April 5, 2017

* RXi Pharmaceuticals Corp - deal for number of shares equal to 19.99% of then outstanding shares of common stock of RXi

* RXi Pharmaceuticals Corp - entered into an option agreement to acquire all outstanding capital stock of Mirimmune Inc

* RXi Pharmaceuticals Corp - deal also provides for additional potential consideration contingent on Mirimmune reaching certain milestones Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below